kyron.bio is heading to Madrid for ESMO Congress 2026, one of the most influential meetings in oncology.

​

​

​

​

​

​

​

​

​

​

​

​

​

​​

​

 

We look forward to joining the conversation on next-generation cancer therapeutics. Our Head of R&D, Dr. Marina Lochhead, will be attending and would be glad to meet oncology researchers, clinicians and partners interested in how glycoengineering can enhance antibody therapeutics.
 

Attending ESMO? We look forward to meeting you in Madrid! Get in touch through our contact page to arrange a meeting.